ACTRN12613001370796已完成3 期
A multi-centre, cluster randomised, double cross over, feasibility trial investigating the effect of using 0.9% saline or Plasma-lyte 148 as fluid therapy on the risk of developing acute kidney injury in intensive care patients
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 2,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- o limit 至 o limit（—）
- 性别
- All
入选标准
- •Patients admitted to the study ICU who require crystalloid fluid therapy
排除标准
- •1. patients currently receiving or expected to require renal replacement therapy within six hours of ICU admission 2. patients who are usually on dialysis for end stage renal failure 3. patients who are admitted to the ICU solely for consideration of organ donation or for palliative care 4. patients previously enrolled in the SPLIT study
研究者
相似试验
尚未招募
2 期
A multicentre, cluster randomised, double cross over pragmatic clinical trial comparing the safety and efficacy of enteral olanzapine with quetiapine in critically ill patients with hyperactive deliriumcritical illnesshyperactive deliriumNeurological - Other neurological disordersACTRN12622001532796Royal Melbourne Hospital1,200
进行中（未招募）
1 期
Gaviscon Double Action pH monitoring study.This study is to demonstrate the antacid action of Gaviscon Double Action Mint versus a matched placebo using a pH catheter.EUCTR2012-004131-23-GBReckitt Benckiser Healthcare (UK) Ltd25
已完成
不适用
A multicentre, parallel group, randomised, double blind study to investigate the efficacy of fluticasone 100 mcg metered dose inhaler (MDI) twice a day (bd) versus placebo MDI bd both via Babyhaler® spacer in 1 to 5 year old children with asthma or asthma-like symptoms during a 6 month study periodAsthmaRecurrent respiratory symptoms in childrenRespiratoryISRCTN04517206GlaxoSmithKline (The Netherlands)96
进行中（未招募）
1 期
Reperfusion thrombolytic therapy for ischemic stroke in patients on the non-vitamin K antagonist oral anticoagulants.EUCTR2020-004898-41-PLMEDICAL UNIVERSITY OF GDANSK300
进行中（未招募）
1 期
A multicenter, randomized, parallel-group, double-blind, placebo-controlled trial to evaluate the efficacy and safety of four different doses of Org 50081 in the treatment of moderate to severe vasomotor symptoms associated with the menopausemoderate to severe vasomotor symptoms associated with the menopauseMedDRA version: 7.0 Level: LLT Classification code 10020411EUCTR2004-000472-14-ESV Organon900